
|Articles|July 1, 2003
Santen seeks OK for concentrated antibiotic
Napa, CA-Santen Pharmaceutical Co. is hoping that its higher-concentration ocular antibiotic will set a new standard for treatment of bacterial corneal ulcers.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement


















































.png)


